0001140361-23-039344.txt : 20230811
0001140361-23-039344.hdr.sgml : 20230811
20230811212220
ACCESSION NUMBER: 0001140361-23-039344
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lundbeckfond Invest A/S
CENTRAL INDEX KEY: 0001591046
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 231165900
BUSINESS ADDRESS:
STREET 1: SCHERFIGSVEJ 7
CITY: COPENHAGEN
STATE: G7
ZIP: DK-2100
BUSINESS PHONE: 4540307375
MAIL ADDRESS:
STREET 1: SCHERFIGSVEJ 7
CITY: COPENHAGEN
STATE: G7
ZIP: DK-2100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0508
4
2023-08-09
0001865494
IO Biotech, Inc.
IOBT
0001591046
Lundbeckfond Invest A/S
C/O IO BIOTECH, INC.
OLE MAALOES VEJ 3
COPENHAGEN
G7
2200
DENMARK
true
true
false
Common Stock
2023-08-09
4
A
0
7901234
1.9
A
13950686
D
Warrants (Right to Buy)
2.47
2023-08-09
4
A
0
7901234
0.125
A
2023-08-09
Common Stock
7901234
7901234
D
These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).
Christian Elling is Managing Partner of Lundbeckfonden Emerge, a division of Lundbeckfond Invest A/S, and currently serves as the representative of Lundbeckfond Invest A/S on the Issuer's board of directors, and therefore Lundbeckfond Invest A/S may be deemed a "director by deputization" of the Issuer.
Lundbeckfond Invest A/S, by: /s/ Brian Burkavage, Attorney-in-Fact for Christian Elling, Managing Partner, and Lene Skole, Chief Executive Officer
2023-08-11